{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:42:54Z","timestamp":1782783774600,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.adro.2017.03.006","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T17:48:24Z","timestamp":1490636904000},"page":"325-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus"],"prefix":"10.1016","volume":"2","author":[{"given":"Cai","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuko","family":"Komaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Balter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2017.03.006_bib1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3748\/wjg.v16.i13.1649","article-title":"Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma","volume":"16","author":"Lv","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.adro.2017.03.006_bib3","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.adro.2017.03.006_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.radonc.2005.10.017","article-title":"Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer","volume":"77","author":"Chandra","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ijrobp.2011.10.053","article-title":"Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer","volume":"83","author":"Kole","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2017.03.006_bib6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2012.02.015","article-title":"Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer","volume":"84","author":"Lin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2017.03.006_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/cncr.29857","article-title":"Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer","volume":"122","author":"Lin","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2017.03.006_bib8","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1118\/1.3453575","article-title":"Fundamental properties of the delivery of volumetric modulated arc therapy (VMAT) to static patient anatomy","volume":"37","author":"Rangaraj","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2017.03.006_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/dote.12144","article-title":"Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: Volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy","volume":"27","author":"Lin","year":"2014","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.adro.2017.03.006_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.meddos.2010.09.009","article-title":"Volumetric modulated arc therapy vs. IMRT for the treatment of distal esophageal cancer","volume":"36","author":"Van Benthuysen","year":"2011","journal-title":"Med Dosim"},{"key":"10.1016\/j.adro.2017.03.006_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13014-014-0243-1","article-title":"Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates","volume":"9","author":"Yamashita","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.radonc.2013.08.006","article-title":"Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome","volume":"109","author":"Fonteyne","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib13","doi-asserted-by":"crossref","first-page":"e0129679","DOI":"10.1371\/journal.pone.0129679","article-title":"Clinical outcomes of volume-modulated arc therapy in 205 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.adro.2017.03.006_bib14","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.ijrobp.2010.09.014","article-title":"Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: A comparison with intensity-modulated radiotherapy techniques","volume":"81","author":"Holt","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2017.03.006_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-717X-8-26","article-title":"Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head-and-neck cancer: A planning study","volume":"8","author":"Holt","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2011.12.041","article-title":"Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study","volume":"84","author":"Nicolini","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2017.03.006_bib17","first-page":"1756","article-title":"The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer","volume":"47","author":"Gayed","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.adro.2017.03.006_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","article-title":"Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy","volume":"70","author":"Wei","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2017.03.006_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1748-717X-8-75","article-title":"Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma","volume":"8","author":"Tu","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1748-717X-9-191","article-title":"Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer","volume":"9","author":"Roeder","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1442-2050.2009.01004.x","article-title":"Multimodality treatment with intensity modulated radiation therapy for esophageal cancer","volume":"23","author":"La","year":"2010","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.adro.2017.03.006_bib22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/01.sla.0000161983.82345.85","article-title":"Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)","volume":"241","author":"Swisher","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.adro.2017.03.006_bib23","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1200\/JCO.2005.05.017","article-title":"Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival","volume":"23","author":"Berger","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib24","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-009-0862-1","article-title":"Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer","volume":"17","author":"Meredith","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/annonc\/mdh219","article-title":"A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma","volume":"15","author":"Lee","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for esophageal adenocarcinoma","volume":"335","author":"Walsh","year":"1996","journal-title":"New Eng J Med"},{"key":"10.1016\/j.adro.2017.03.006_bib27","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1200\/JCO.2008.16.6918","article-title":"Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113","volume":"26","author":"Ajani","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib28","doi-asserted-by":"crossref","first-page":"S1357","DOI":"10.1245\/s10434-015-4619-8","article-title":"Predictive factors of recurrence in patients with pathological complete response after esophagectomy following neoadjuvant chemoradiotherapy for esophageal cancer: a multicenter study","volume":"22","author":"Luc","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib29","first-page":"391","article-title":"A prospective study of combined therapy in esophageal cancer","volume":"41","author":"Apinop","year":"1994","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.adro.2017.03.006_bib30","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/1097-0142(19940401)73:7<1779::AID-CNCR2820730702>3.0.CO;2-T","article-title":"A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus","volume":"73","author":"Le Prise","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2017.03.006_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","article-title":"Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus","volume":"337","author":"Bosset","year":"1997","journal-title":"New Engl J Med"},{"key":"10.1016\/j.adro.2017.03.006_bib32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial","volume":"6","author":"Burmeister","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2017.03.006_bib33","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2013.04.006","article-title":"Predictors of postoperative complications after trimodality therapy for esophageal cancer","volume":"86","author":"Wang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109417300544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109417300544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:35:19Z","timestamp":1762529719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109417300544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2452109417300544"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2017.03.006","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2017.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 the Authors. Published by Elsevier Inc. on behalf of the American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}